Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1639449405;49406;49407 chr2:178614217;178614216;178614215chr2:179478944;179478943;179478942
N2AB1475344482;44483;44484 chr2:178614217;178614216;178614215chr2:179478944;179478943;179478942
N2A1382641701;41702;41703 chr2:178614217;178614216;178614215chr2:179478944;179478943;179478942
N2B732922210;22211;22212 chr2:178614217;178614216;178614215chr2:179478944;179478943;179478942
Novex-1745422585;22586;22587 chr2:178614217;178614216;178614215chr2:179478944;179478943;179478942
Novex-2752122786;22787;22788 chr2:178614217;178614216;178614215chr2:179478944;179478943;179478942
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: D
  • RefSeq wild type transcript codon: GAT
  • RefSeq wild type template codon: CTA
  • Domain: Fn3-6
  • Domain position: 44
  • Structural Position: 54
  • Q(SASA): 0.6269
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
D/N rs765265590 0.517 1.0 N 0.53 0.361 0.241078983079 gnomAD-2.1.1 8.08E-06 None None None None N None 0 5.82E-05 None 0 0 None 0 None 0 0 0
D/N rs765265590 0.517 1.0 N 0.53 0.361 0.241078983079 gnomAD-4.0.0 3.18734E-06 None None None None N None 0 4.58379E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
D/A 0.3351 likely_benign 0.3151 benign 0.034 Stabilizing 1.0 D 0.633 neutral N 0.484788587 None None N
D/C 0.8009 likely_pathogenic 0.7629 pathogenic 0.148 Stabilizing 1.0 D 0.709 prob.delet. None None None None N
D/E 0.2497 likely_benign 0.252 benign -0.247 Destabilizing 1.0 D 0.396 neutral N 0.479021142 None None N
D/F 0.8335 likely_pathogenic 0.8171 pathogenic -0.153 Destabilizing 1.0 D 0.685 prob.neutral None None None None N
D/G 0.2215 likely_benign 0.2014 benign -0.063 Destabilizing 1.0 D 0.544 neutral N 0.457674488 None None N
D/H 0.5541 ambiguous 0.5286 ambiguous 0.284 Stabilizing 1.0 D 0.59 neutral N 0.480168333 None None N
D/I 0.6689 likely_pathogenic 0.6405 pathogenic 0.219 Stabilizing 1.0 D 0.699 prob.neutral None None None None N
D/K 0.7065 likely_pathogenic 0.6716 pathogenic 0.595 Stabilizing 1.0 D 0.595 neutral None None None None N
D/L 0.6637 likely_pathogenic 0.632 pathogenic 0.219 Stabilizing 1.0 D 0.701 prob.neutral None None None None N
D/M 0.813 likely_pathogenic 0.8055 pathogenic 0.195 Stabilizing 1.0 D 0.703 prob.neutral None None None None N
D/N 0.146 likely_benign 0.142 benign 0.434 Stabilizing 1.0 D 0.53 neutral N 0.471629288 None None N
D/P 0.8847 likely_pathogenic 0.8723 pathogenic 0.176 Stabilizing 1.0 D 0.599 neutral None None None None N
D/Q 0.6189 likely_pathogenic 0.5998 pathogenic 0.421 Stabilizing 1.0 D 0.592 neutral None None None None N
D/R 0.7541 likely_pathogenic 0.7234 pathogenic 0.674 Stabilizing 1.0 D 0.665 neutral None None None None N
D/S 0.2014 likely_benign 0.1935 benign 0.347 Stabilizing 1.0 D 0.542 neutral None None None None N
D/T 0.3372 likely_benign 0.3241 benign 0.427 Stabilizing 1.0 D 0.597 neutral None None None None N
D/V 0.4724 ambiguous 0.4468 ambiguous 0.176 Stabilizing 1.0 D 0.703 prob.neutral N 0.486545749 None None N
D/W 0.963 likely_pathogenic 0.9544 pathogenic -0.141 Destabilizing 1.0 D 0.708 prob.delet. None None None None N
D/Y 0.4999 ambiguous 0.4569 ambiguous 0.066 Stabilizing 1.0 D 0.676 prob.neutral D 0.565678018 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.